RECENT FEATURE ARTICLES
Supply chain interruption or restriction is becoming a fact of life, both in the clinical laboratory and in the wider healthcare environment. Here, Tony Cambridge considers the various issues affecting the supply of consumables to the near-patient testing arena.
While genomic methods are gaining importance across pathology, especially in infection sciences and tissue sciences, the application of routine staining methods continues to complement 21st-century technology. The following papers include the use of Christian Gram’s eponymous method or that named after two German doctors, the bacteriologist Franz Ziehl and pathologist Friedrich Neelsen.
Currently, there is a move in healthcare that would see a range of diagnostic services relocated from hospitals into the urban environment of town and city centres, to facilitate easier patient access. Here, Tony Cambridge focuses on a selection of models proposed for the delivery of in vitro diagnostic testing outside the traditional laboratory and in the community.
Automating tissue dissection would appear to hold the key to personalised medicine becoming a reality. Here, Pathology in Practice has been given an early look at a new Xyall solution for the molecular pathology laboratory.
Pathology in Practice asked ARKRAY general manager David Eyre to provide insights into overall trends while assessing the current UK situation post-COVID. He offers a solution for speeding up all HbA1c testing, increasing throughput for routine tests while reducing unnecessary testing for variants.
Introducing a new, high-sensitivity test to detect blood-based biomarkers of mild traumatic brain injury within 12 hours of head trauma, which gives clinicians the power to predict the absence of intracranial lesions in adult patients with suspected mild traumatic brain injury.
Sepsis improvement programmes have received criticism in recent years, with some claiming that they have resulted in increased hospital antimicrobial consumption. But should we be targeting sepsis management or should we be looking elsewhere for solutions, including better integration of diagnostics? Louise Frampton reports.
Group B Streptococcus is the most common cause of life-threatening infection in newborns, and in the UK on average two babies a day develop the infection. Now, the charity Group B Strep Support has called for greater awareness of the disease and for hospitals to enroll in the ongoing GBS3 trial.
North West London Pathology has developed a hub-and-spoke network with clinical need at its forefront across seven hospital sites, supported by Stago UK’s resources and its reputation for adaptability.
The Genomic & Microbiology Revolution: In Technology we Trust? was the title of the 37th Annual Microbiology Conference of the British Society for Microbial Technology, held at the RAF Museum at Hendon on 19 July. A fascinating programme looked at a range of different aspects of technology applied to microbiology, here summarised by Mark Wilks on behalf of the BSMT committee.
Point-of-care testing has found application across the breadth of healthcare, a recent prime example being the role of viscoelastic POC testing in post-partum bleeding management in obstetrics.
Polio has returned to the media spotlight recently after the discovery of the virus in London sewage. The following is a selection of free-to-access research interest in this year’s scientific literature on the subject of this small, single-stranded RNA virus.
Whole-genome sequencing is a comprehensive method for analysing entire genomes and has been instrumental in identifying, for example, inherited disorders and the mutations that drive cancer development. Here, PerkinElmer genomics specialist Anona Bamford provides an insight into the enigma that is the study of deoxyribonucleic acid.
The use of xylene-free processing in histopathology has gained ground in recent years, supported by the latest developments in tissue processor technology. Here, Epredia customers in Germany provide examples of the advantages to processes and personnel gained through a simple change in methodology.
The healthcare environment continues to present a risk of infection transmission, so what can we do to protect patients in a post-pandemic era? The Central Sterilising Club’s 60th anniversary annual scientific meeting showcased the latest evidence for best practice, highlighting some of the potential threats that need to be addressed.
Although the exact cause of pre-eclampsia is not known, it is thought to occur when a problem develops with the placenta. Routine blood pressure and proteinuria checks are performed during the antenatal period to detect this condition, and can now be complemented by the addition of near-patient placental growth factor testing.
Mycobacterium ulcerans infection results in a debilitating disease that is characterised by extensive and severe destruction of the skin and subcutaneous tissue. Adewale Oke and colleagues report on a study that aimed to identify cases of so-called Buruli ulcer in five states of south-west Nigeria.
The CliniSys national conference returned to The Belfry after a two-year hiatus to debate the big challenges facing the NHS and its pathology services. Matthew Fouracre reports.
The North East Innovation Lab works to assess and accelerate the development of new diagnostic tests. Pathology in Practice looks at the support it provided to a study assessing the use of synthetic polymer antibodies in a new test for SARS-CoV-2.
Point-of-care testing for the SARS-CoV-2 has expanded exponentially over the past two years, resulting in the need for an external quality assessment scheme for this activity. Here, Heather Crowton and colleagues introduce a new EQA scheme.